INTRODUCTION: Subcutaneous mastectomy is the first surgical procedure to be completed by female to male transsexuals after appropriate mental health and endocrine therapy. Objectives of subcutaneous mastectomy in this group are to masculinize the chest by the removal of breast tissue and skin excess, reduction and proper positioning of the nipple-areola complex, obliteration of the infra-mammary fold, and ideally with a minimal of chest wall scars. In this study, the largest series of subcutaneous mastectomies in female-to-male transsexuals to date is presented. AIMS: Our aim was to determine relations between surgical technique, risk factors, complications, reoperations and secondary corrections in female-to-male transsexuals. METHODS: We performed a retrospective survey study on 404 mastectomies in 202 female-to-male transsexuals during the period of 2000-2011. MAIN OUTCOME MEASURES: Primary outcomes for this study were complication rate, acute reoperations, secondary corrections, surgical time, and length of hospital stay in relation to the surgical technique used. RESULTS: The average age of these patients at time of the intervention was 31 years (±10) with an average BMI of 25 kg/m(2) (±4). The chosen technique depended strongly on breast volume, which, in turn, was strongly related to BMI and age. The number of acute reoperations and secondary corrections depended on the surgical technique. The total rate of acute complications was 5.0%. This percentage was highest in surgeries without skin resection (10.5%). To improve overall aesthetic results, the following secondary corrections were performed: nipple and/or areola corrections (8.9%), scar revisions (12.6%), and chest contouring (17.8%). CONCLUSION: This study shows a correlation between the surgical technique, complication rate, and length of hospital stay. In general, the larger the breast, the larger the scars that remain after the operation. On the other hand, the smaller the scars resulting from the operation, the higher the risk of hematoma.
INTRODUCTION: Subcutaneous mastectomy is the first surgical procedure to be completed by female to male transsexuals after appropriate mental health and endocrine therapy. Objectives of subcutaneous mastectomy in this group are to masculinize the chest by the removal of breast tissue and skin excess, reduction and proper positioning of the nipple-areola complex, obliteration of the infra-mammary fold, and ideally with a minimal of chest wall scars. In this study, the largest series of subcutaneous mastectomies in female-to-male transsexuals to date is presented. AIMS: Our aim was to determine relations between surgical technique, risk factors, complications, reoperations and secondary corrections in female-to-male transsexuals. METHODS: We performed a retrospective survey study on 404 mastectomies in 202 female-to-male transsexuals during the period of 2000-2011. MAIN OUTCOME MEASURES: Primary outcomes for this study were complication rate, acute reoperations, secondary corrections, surgical time, and length of hospital stay in relation to the surgical technique used. RESULTS: The average age of these patients at time of the intervention was 31 years (±10) with an average BMI of 25 kg/m(2) (±4). The chosen technique depended strongly on breast volume, which, in turn, was strongly related to BMI and age. The number of acute reoperations and secondary corrections depended on the surgical technique. The total rate of acute complications was 5.0%. This percentage was highest in surgeries without skin resection (10.5%). To improve overall aesthetic results, the following secondary corrections were performed: nipple and/or areola corrections (8.9%), scar revisions (12.6%), and chest contouring (17.8%). CONCLUSION: This study shows a correlation between the surgical technique, complication rate, and length of hospital stay. In general, the larger the breast, the larger the scars that remain after the operation. On the other hand, the smaller the scars resulting from the operation, the higher the risk of hematoma.
Authors: Samyd S Bustos; Doga Kuruoglu; Maria Yan; Valeria P Bustos; Antonio J Forte; Pedro Ciudad; Esther A Kim; Gabriel A Del Corral; Oscar J Manrique Journal: Ann Transl Med Date: 2021-04
Authors: Joseph Gerth; Tracy Becerra-Culqui; Andrew Bradlyn; Darios Getahun; Enid M Hunkeler; Timothy L Lash; Andrea Millman; Rebecca Nash; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Vin Tangpricha; Suma Vupputuri; Michael Goodman Journal: Rev Endocr Metab Disord Date: 2018-09 Impact factor: 6.514
Authors: Annie Tang; J Carlo Hojilla; Jordan E Jackson; Kara A Rothenberg; Rebecca C Gologorsky; Douglas A Stram; Colin M Mooney; Stephanie L Hernandez; Karen M Yokoo Journal: Ann Plast Surg Date: 2022-05 Impact factor: 1.763
Authors: Tim C van de Grift; Lian Elfering; Mark-Bram Bouman; Marlon E Buncamper; Margriet G Mullender Journal: Plast Reconstr Surg Date: 2017-09 Impact factor: 4.730
Authors: R Craig Sineath; Cory Woodyatt; Travis Sanchez; Shawn Giammattei; Theresa Gillespie; Enid Hunkeler; Ashli Owen-Smith; Virginia P Quinn; Douglas Roblin; Robert Stephenson; Patrick S Sullivan; Vin Tangpricha; Michael Goodman Journal: Transgend Health Date: 2016-07-01
Authors: Alexander Kamali; Hannes Sigurjónsson; Isak Gran; Filip Farnebo; Kalle Conneryd Lundgren; Fredrik Granath; Pehr Sommar Journal: Plast Reconstr Surg Glob Open Date: 2021-07-13